Most of the time, more money is spent to get additional benefits relative to standards of care
High-dose intravenous protocols (up to 50 mg/kg daily, ~3,500 mg for a 70 kg person) have been used safely in patients with metabolic disorders [8] , indicating a wide therapeutic margin
A few months after starting a low-dose GLP-1, her flares dropped to about one a month, her energy came back, and we began tapering her medications instead of adding more
Its value in a clinical setting comes from what it is not: it does not disrupt appetite, hormones, insulin, or IGF-1
Although the study found benefits, it also discovered some increased risks associated with the drugs
This is similar to telogen effluvium seen with any significant weight loss, regardless of the method used